Bluebird bio
BLUEbluebird bio, Inc., based in Cambridge, Massachusetts, is a biotechnology company that develops gene therapies for severe genetic disorders and cancer.The company's only - in the European Union (EU) - approved drug is betibeglogene autotemcel (Zynteglo), which treats transfusion-dependent beta thala …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2023-2025
All insider trades at Bluebird bio
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 3/3/2025 | Sell | Obenshain, Andrew | President and CEO | $3.9 | $3,610 |
| 3/3/2025 | Sell | Klima, Thomas J. | Officer | $3.9 | $1,960 |
| 3/3/2025 | Sell | Colvin, Richard A. | Chief Medical Officer | $3.9 | $2,289 |
| 2/3/2025 | Sell | Obenshain, Andrew | President and CEO | $7.4 | $636 |
| 2/3/2025 | Sell | Vittiglio, Joseph | Chief Business & Legal Officer | $7.4 | $1,759 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)